Literature DB >> 6785531

Purification of human interleukin 1.

L B Lachman, S O Page, R S Metzgar.   

Abstract

Interleukin I (IL-1) is a lymphocyte stimulant released by human monocytes cultured for 18-24 hours in tissue culture medium containing 5% serum and the non-specific immunostimulant lipopolysaccharide (LPS). Human IL-1 is found in the conditioned medium in a low molecular weight (approximately 13,000) and a high molecular weight (approximately 85,000) form. The high MW activity may result from the formation of a complex between IL-1 and serum constituents. During the course of purification, the low MW IL-1 activity is often recovered in a high MW form. Hollow fiber diafiltration and membrane ultrafiltration has been found to rapidly separate low MW IL-1 from all measurable protein with a yield of 4% of the original activity. The IL-1 which converts to the high MW form during the purification is recoverable, 21% of the original activity, but contains small amounts of serum proteins. Isoelectric focusing (IEF) of the low MW IL-1 resulted in a very highly purified sample which was analyzed by polyacrylamide gel electrophoresis (PAGE). Utilizing a new staining procedure which detects less than 1 ng of protein per band, the IEF-purified IL-1 revealed trace quantities (less than 1 ng) of a slowly migrating protein similar to immunoglobulin and no other bands. There were no bands which corresponded with the known electrophoretic mobility of IL-1. Since the samples applied to the gel contained significant biological activity, this result implies that human IL-1 is biologically active in picogram quantities.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6785531     DOI: 10.1002/jss.400130405

Source DB:  PubMed          Journal:  J Supramol Struct        ISSN: 0091-7419


  14 in total

1.  Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum.

Authors:  L C Gahring; A Buckley; R A Daynes
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

Review 2.  Heberden Oration 1980: aspects of the cell biology of the rheumatoid synovial lesion.

Authors:  S M Krane
Journal:  Ann Rheum Dis       Date:  1981-10       Impact factor: 19.103

Review 3.  Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease.

Authors:  W Sue T Griffin; Robert E Mrak
Journal:  J Leukoc Biol       Date:  2002-08       Impact factor: 4.962

Review 4.  Immune regulators of inflammation in obesity-associated type 2 diabetes and coronary artery disease.

Authors:  Katherine J Strissel; Gerald V Denis; Barbara S Nikolajczyk
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

5.  Interleukin-1 beta and interleukin-1 alpha stimulate the N-acetyl-beta-glucosaminidase activity of human synovial cells.

Authors:  B J Clarris; J R Fraser; P Ash; T Leizer; J A Hamilton
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

6.  Diverse morphological responses of normal human synovial fibroblasts to mononuclear leukocyte products: relationship to prostaglandin production and plasminogen activator activities, and comparison with the effects of purified interleukin 1.

Authors:  B J Clarris; T Leizer; J R Fraser; J A Hamilton
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

7.  Characterization and specificity of a high titre polyclonal goat anti-murine IL-1 antibody.

Authors:  M E Scheetz; D G Carlson; J L Bobbitt; L D Butler; S H Zuckerman
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

8.  Trichothecene mycotoxins in aerosolized conidia of Stachybotrys atra.

Authors:  W G Sorenson; D G Frazer; B B Jarvis; J Simpson; V A Robinson
Journal:  Appl Environ Microbiol       Date:  1987-06       Impact factor: 4.792

9.  Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis.

Authors:  R Pacifici; L Rifas; S Teitelbaum; E Slatopolsky; R McCracken; M Bergfeld; W Lee; L V Avioli; W A Peck
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

10.  Effect of interleukin 1 on human thymocytes and purified human T cells.

Authors:  A L Maizel; S R Mehta; R J Ford; L B Lachman
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.